Health Condition 1: C50-C50- Malignant neoplasms of breast Health Condition 2: C15-C26- Malignant neoplasms of digestive organs Health Condition 3: C51-C58- Malignant neoplasms of female genital organs Health Condition 4: C00-C14- Malignant neoplasms of lip, oral cavity and pharynx Health Condition 5: C45-C49- Malignant neoplasms of mesothelial and soft tissue Health Condition 6: C30-C39- Malignant neoplasms of respiratory and intrathoracic organs Health Condition 7: C64-C68- Malignant neoplasms
Conditions
Interventions
Intervention1: Nil: Nil
Sponsors
Strand Life Sciences Pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: Patients with confirmed malignant carcinoma as defined above who are eligible for mono-immuno-oncology therapy and will undergo the treatment, as identified by the site Principal Investigator or Co-Investigators through routine clinical care processes Age - 18 years and above Both men and women of all races and ethnic groups are eligible for this study New, relapsed, recurrent or metastatic cases Ability to understand and the willingness to sign a written Informed Consent Form
Exclusion criteria
Exclusion criteria: Pregnant or lactating women Patients who have untreated active infection Patients who are receiving any additional oncology investigational agent(s) with immuno-oncology drugs Patients undergoing combinatorial immunotherapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Identification of signature biomarkers via a minimally invasive procedure will enable distinguishing between mono immunooncology drug responder & nonresponder or patient prognosis while on mono immunotherapy for cancer.Timepoint: 13 (before therapy starts and every month for period of 12 months) | — |
Secondary
| Measure | Time frame |
|---|---|
| Identification of reliable predictive molecular markers to distinguish responders & non-responders for immuno-oncology drugsTimepoint: 13 (before therapy starts & every month for period of 12 months) | — |
Countries
India
Contacts
Public ContactDr Vamsi Veeramachaneni
Strand Life Sciences Pvt Ltd
Outcome results
None listed